119-HR-7949 Journalist Public Summary
119 · HR 7949 NSF Plant Biology Act
Bipartisan House bill would let the National Science Foundation fund fundamental plant and microbial biology with potential benefits for agriculture, food, and biotechnology—authorizing $150 million per year from FY2026–FY2031; it was introduced on March 16, 2026 and sent to the House Science Committee.
Headline Summary
A bipartisan bill would expand the National Science Foundation’s ability to fund basic plant and microbial biology research tied to agriculture, food, and biotechnology, with $150 million authorized annually through FY2026–FY2031.
What It Does
H.R. 7949 amends the National Science Foundation Authorization Act of 2002 to let NSF award competitive, merit-reviewed grants to universities, nonprofits, private companies, and government entities (including Tribal governments) for fundamental plant biology and enabling tools, resources, and technologies with potential relevance to agriculture, food, or biotech. It authorizes $150 million per year for FY2026–FY2031 and adds a definition clarifying that eligible “nonprofit organizations” are 501(c)(3) tax‑exempt groups.
Who’s For It
- Lead sponsors: Rep. Josh Riley (D‑NY) and Rep. James Baird (R‑IN).
- Bipartisan framing: Supporters highlight basic research with potential payoffs for crop productivity, food security, and biotechnology—aimed at keeping U.S. science competitive and helping universities and research partners advance plant biology.
Who’s Against It
- No formal opposition noted at introduction.
- Possible concerns often raised about similar bills include: overall spending levels; whether NSF’s role overlaps with USDA’s applied research; the difference between basic research and near‑term farm needs; and debates over biotechnology and genetic engineering. These are possibilities, not documented positions on this specific bill.
What’s Next
Status as of March 16, 2026: Introduced in the House and referred to the Committee on Science, Space, and Technology. Next typical steps would be a committee hearing and markup, a committee vote, a House floor vote, then consideration in the Senate and, if passed, the President’s signature.
Discussion